Malcolm SAL, Díaz JGL, Leyva FD

Language: Spanish
References: 11
Page: 1210-1220
PDF size: 423.45 Kb.

ABSTRACT

Peripheral steroid-producing tumors are rare entities and are potentially malignant. Testosterone is the most commonly elevated hormone and is mostly associated with signs of virilization. A case of a 62-year-old patient with a giant virilizing ovarian granulose cell tumor was diagnosed. Scheduled laparotomy was performed with freezing biopsy and total abdominal hysterectomy with double anixectomy plus omentectomy. I evolve favorably without complications. The case reported here is that of a patient with a history of apparent health, regular menstruations, with an obstetric history of 4 gestations and having been operated on at 24 years of a fetal heart rate, before a table of virilization syndrome were used data from hospital medical history, complementary examinations, interview and physical examination of the patient. Despite the time of evolution presented by the patient with the giant virilizing tumor of cells of the left ovary granulose, the operation was a success and the evolution has been satisfactory, thanks to the work of the medical staff who were in charge of the case, demonstrating once again the strengths of the Cuban health system in situations like these.

REFERENCES

1. Huerta Sáenz I. Criterios sonogáficos de evaluación de malignidad de tumores de ovario Metodología IOTA (International Ovarian Tumor Analysis Group). Rev Peru Ginecol Obstet 2019; 65(3): 311-315.

2. Jacobs IJ, Menon U, Ryan A, Gentry-Maharaj A, Burnell M, Kalsi JK, et al. Ovarian cancer screen-ing and mortality in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a ran-domised controlled trial. Lancet 2016; 387(10022): 945-56.

3. Timmerman D, Van Calster B, Testa AC, Savelli L, Fischerova D, Froyman W, et al. Predict-ing the risk of malignancy in adnexal masses based on the Simple Rules from the International Ovarian Tumor Analysis group. Am J Obstet Gynecol 2016; 214(4): 424-437.

4. Li YK. CT imaging of ovarian yolk sac tumor with emphasis on differential diagnosis. Sci Rep [Internet]. 2015 [citado 2/8/2019]; 5. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4466583/

5. Cai-Yan L. Clinical experience of uterine tumors resembling ovarian sex cord tumors: a clinic pathological analysis of 6 cases. Int J Clin Exp Pathol 2015; 8(4): 4158-4164.

6. Spinelli C, Pucci V, Strambi S, Lo Piccolo R, Martin A, Messineo A. Treatment of ovarian lesions in children and adolescents: a retrospective study of 130 cases. Pediatr Hematol Oncol 2015; 32(3): 199-206.

7. Spinelli C, Strambi S, Liloia C, Bertocchini A, Messineo A. Update on the surgical management of ovarian neoplasms in children and adolescents: analysis on 32 cases. Gynecol Endocrinol 2016; 32(10): 787-91.

8. Mariampillai AI, Cruz JPD, Suh J, Sivapiragasam A, Nevins K, Hindenburg AA. Cancer Antigen 72-4 for the Monitoring of Advanced Tumors of the Gastrointestinal Tract, Lung, Breast and Ovaries. Anticancer Res 2017; 37(7): 3649-56.

9. Abbas PI, Dietrich JE, Francis JA, Brandt ML, Cass DL, Lopez ME. Ovarian-sparing surgery in pediatric benign ovarian tumors. J Pediatr Adolesc Gynecol 2016; 29(5): 506-10.

10. Blake EA, Sheridan TB, Wang KL, Takiuchi T, Kodama M. Clinical characteristics and outcomes of uterine tumors resembling ovarian sex-cord tumors (UTROSCT): a systematic review of literature. Eur J ObstetGynecolReprod Biol 2014; 181: 163–170.

11. Instituto Nacional del Cáncer. Tratamiento de los tumores extragonadales de células germinativas (PDQ®). Instituto Nacional del Cáncer. [Internet]. 2014 [Citado 5/8/2019]. Disponible en: https://www.cancer.gov/espanol/tipos/extragonadal-celulas-germinativas/pro/tratamiento-extragonadal-pdq